Literature DB >> 17332611

Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study.

Sharmila Dorbala1, Divya Vangala, Uchechukwu Sampson, Atul Limaye, Raymond Kwong, Marcelo F Di Carli.   

Abstract

UNLABELLED: Our aim was to determine the value of vasodilator left ventricular ejection fraction (LVEF) reserve (stress ejection fraction - rest ejection fraction) in evaluating the magnitude of myocardium at risk and the anatomic extent of underlying severe coronary artery disease (CAD).
METHODS: We studied 510 consecutive patients with suspected CAD undergoing gated rest and vasodilator stress (82)Rb PET/CT. Patients were categorized as having no perfusion abnormalities, mild, moderate, or severe reversible perfusion defects. In a subgroup of 68 patients with coronary angiography, patients were categorized as having 0-vessel, 1-vessel, 2-vessel, or left main/3-vessel disease.
RESULTS: Patients without coronary risk factors who comprised our control group as well as patients with coronary risk factors and normal perfusion demonstrated a high LVEF reserve (7% +/- 7% and 5% +/- 6%, respectively). The mean LVEF reserve was negative (-0.2% +/- 8%) in patients with severe reversible defects and in patients with 3-vessel (-6% +/- 8%) and left main (-8% +/- 5%) disease. Among the clinical and scintigraphic variables studied, male sex, rest ejection fraction, and increasing magnitude of myocardium at risk predicted a lower LVEF reserve, whereas LVEF reserve was the only independent predictor of left main/3-vessel disease (P = 0.008). An LVEF reserve of more than +5% had a positive predictive value of only 41% but a negative predictive value of 97% for excluding severe left main/3-vessel CAD.
CONCLUSION: During (82)Rb PET/CT, LVEF increases with vasodilator stress in patients without significant stress-induced perfusion defects or severe left main/3-vessel CAD. A high LVEF reserve appears to be an excellent tool to exclude left main/3-vessel CAD noninvasively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332611

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  92 in total

1.  Ischemic changes on rubidium-82 positron emission tomography imaging are associated with left ventricular functional and volumetric change independent of metabolic properties and echocardiographic functional variables in ischemic cardiomyopathy.

Authors:  Raymond C Wong; Manuel D Cerqueira; Richard C Brunken
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-11       Impact factor: 2.357

Review 2.  Myocardial perfusion scintigraphy: past, present and future.

Authors:  A Notghi; C S Low
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Prognostic implications of post-stress ejection fraction decrease detected by gated SPECT in the absence of stress-induced perfusion abnormalities.

Authors:  Manjola Dona; Lucia Massi; Leonardo Settimo; Matteo Bartolini; Gianluca Giannì; Alberto Pupi; Roberto Sciagrà
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03       Impact factor: 9.236

4.  Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro.

Authors:  Rob S B Beanlands; George Youssef
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 5.  Left main coronary artery disease: A review of the spectrum of noninvasive diagnostic modalities.

Authors:  Nishtha Sareen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2015-10-20       Impact factor: 5.952

6.  Myocardial blood flow: Putting it into clinical perspective.

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

Review 7.  Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM).

Authors:  Roberto Sciagrà; Alessandro Passeri; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Alessia Gimelli; Fabien Hyafil; Denis Agostini; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-05       Impact factor: 9.236

8.  Is it possible for myocardial perfusion imaging to avoid missing any patients with high-risk coronary disease?

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 9.  Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators?

Authors:  Todd D Miller; John Wells Askew; Joerg Herrmann
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

10.  The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated (82)Rb PET myocardial perfusion imaging.

Authors:  Andrew Van Tosh; John R Votaw; Nathaniel Reichek; Christopher J Palestro; Kenneth J Nichols
Journal:  J Nucl Cardiol       Date:  2013-10-04       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.